Search by Drug Name or NDC

    NDC 68382-0446-01 Bosentan 62.5 mg/1 Details

    Bosentan 62.5 mg/1

    Bosentan is a ORAL TABLET, COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Zydus Pharmaceuticals USA Inc.. The primary component is BOSENTAN.

    Product Information

    NDC 68382-0446
    Product ID 68382-446_a8ee488d-716d-48e1-b150-4345366166ca
    Associated GPIs 40160015000320
    GCN Sequence Number 048988
    GCN Sequence Number Description bosentan TABLET 62.5 MG ORAL
    HIC3 B1B
    HIC3 Description PULMONARY ANTI-HTN, ENDOTHELIN RECEPTOR ANTAGONIST
    GCN 14979
    HICL Sequence Number 022990
    HICL Sequence Number Description BOSENTAN
    Brand/Generic Generic
    Proprietary Name Bosentan
    Proprietary Name Suffix n/a
    Non-Proprietary Name Bosentan
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET, COATED
    Route ORAL
    Active Ingredient Strength 62.5
    Active Ingredient Units mg/1
    Substance Name BOSENTAN
    Labeler Name Zydus Pharmaceuticals USA Inc.
    Pharmaceutical Class Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A Inducers [MoA], Endothelin Receptor Antagonist [EPC], Endothelin Receptor Antagonists [MoA]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA207760
    Listing Certified Through 2024-12-31

    Package

    NDC 68382-0446-01 (68382044601)

    NDC Package Code 68382-446-01
    Billing NDC 68382044601
    Package 100 TABLET, COATED in 1 BOTTLE (68382-446-01)
    Marketing Start Date 2019-05-01
    NDC Exclude Flag N
    Pricing Information N/A